SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-018221
Filing Date
2023-03-07
Accepted
2023-03-07 16:05:24
Documents
25
Period of Report
2023-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174778-8k_adialpharma.htm   iXBRL 8-K 36529
2 ADIAL PHARMACEUTICALS, INC. PRESS RELEASE DATED MARCH 6, 2023 ea174778ex99-1_adialpharma.htm EX-99.1 26423
3 ADIAL PHARMACEUTICALS, INC. INVESTOR PRESENTATION DATED MARCH 7, 2023 ea174778ex99-2_adialpharma.htm EX-99.2 15417
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3998
5 GRAPHIC ex99-2_001.jpg GRAPHIC 357162
6 GRAPHIC ex99-2_002.jpg GRAPHIC 237190
7 GRAPHIC ex99-2_003.jpg GRAPHIC 251403
8 GRAPHIC ex99-2_004.jpg GRAPHIC 266417
9 GRAPHIC ex99-2_005.jpg GRAPHIC 370241
10 GRAPHIC ex99-2_006.jpg GRAPHIC 294278
11 GRAPHIC ex99-2_007.jpg GRAPHIC 237860
12 GRAPHIC ex99-2_008.jpg GRAPHIC 305989
13 GRAPHIC ex99-2_009.jpg GRAPHIC 305771
  Complete submission text file 0001213900-23-018221.txt   3935011

Data Files

Seq Description Document Type Size
14 XBRL SCHEMA FILE adil-20230306.xsd EX-101.SCH 3702
15 XBRL DEFINITION FILE adil-20230306_def.xml EX-101.DEF 26516
16 XBRL LABEL FILE adil-20230306_lab.xml EX-101.LAB 36424
17 XBRL PRESENTATION FILE adil-20230306_pre.xml EX-101.PRE 25140
19 EXTRACTED XBRL INSTANCE DOCUMENT ea174778-8k_adialpharma_htm.xml XML 5255
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 23712553
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences